Inventor profile of:

Jon E. Chatterton

City:

Crowley, Texas

Country:

United States

Published Applications:

18

Last publication date:

2009-05-21

Top Assignees for applications by Jon E. Chatterton

The entities that hold a legal rights for patent applications filed by inventor Chatterton Jon E.:

Recent patent applications by Chatterton Jon E.

Jon E. Chatterton from Crowley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2009-05-21
US20090133136A1
Chemistry; metallurgy

Inducible SIRNA expression cassette and method of use

#2 | 2009-05-21
US20090131358A1
Chemistry; metallurgy

LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY

#3 | 2009-02-26
US20090054365A1
Chemistry; metallurgy

RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF OCULAR NEOVASCULARIZATION

#4 | 2009-02-05
US20090036397A1
Chemistry; metallurgy

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA

#5 | 2009-02-05
US20090036396A1
Chemistry; metallurgy

RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS

#6 | 2009-02-05
US20090035225A1
Chemistry; metallurgy

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA

#7 | 2009-01-08
US20090012030A1
Chemistry; metallurgy

RNAi-MEDIATED INHIBITIN OF HTRA1 FOR TREATMENT OF MACULAR DEGENERATION

#8 | 2008-09-04
US20080214486A1
Chemistry; metallurgy

RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS

#9 | 2008-08-14
US20080194513A1
Chemistry; metallurgy

RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF OCULAR NEOVASCULARIZATION

#10 | 2008-07-17
US20080171719A1
Chemistry; metallurgy

RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS

#11 | 2008-02-28
US20080051361A1
Human necessities

RNAI-MEDIATED INHIBITION OF GREMLIN FOR TREATMENT OF IOP-RELATED CONDITIONS

#12 | 2007-12-06
US20070281901A1
Chemistry; metallurgy

RNAI-mediated inhibition of tumor necrosis factor α-related conditions

#13 | 2007-11-29
US20070275922A1
Human necessities

RNAi-MEDIATED INHIBITION OF IGF1R FOR TREATMENT OF OCULAR ANGIOGENESIS

#14 | 2007-07-05
US20070155690A1
Chemistry; metallurgy

RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis

#15 | 2007-06-28
US20070149473A1
Chemistry; metallurgy

RNAi-mediated inhibition of RHO kinase for treatment of ocular disorders

#16 | 2006-10-05
US20060223773A1
Chemistry; metallurgy

RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

#17 | 2006-08-03
US20060172965A1
Chemistry; metallurgy

RNAi-mediated inhibition of ocular targets

#18 | 2006-08-03
US20060172963A1
Chemistry; metallurgy

RNAi-mediated inhibition of ocular hypertension targets

InventorID:

3852250 ⎘